Skip Navigation
National Cancer Institute

Antoinette Percy-Laurry, DrPH, MSPH

Antoinette Percy-Laurry

Title

Public Health Advisor

Phone Number

240-276-6708

Email Address

Antoinette Percy-Laurry, DrPH, MSPH is a Public Health Advisor for the Implementation Science Team in the Office of the Director in the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI).  Dr. Percy-Laurry leads the Cancer Control P.L.A.N.E.T. initiative in Implementation Science at NCI, overseeing the management of relevant data and resources from partner agencies, to assist cancer professionals in designing, implementing and evaluating evidence-based cancer control programs. Dr. Percy-Laurry is also involved in initiatives that address health disparities and support other cancer control activities.  This includes collaborating with various multi-disciplinary workgroups such as Healthy People and the HD*Calc team that promotes the use of the Health Disparities Calculator (HD*Calc) software developed by NCI.

During the years 2004-2014, Dr. Percy-Laurry served on the data quality improvement team and in the Data Analysis and Interpretation Branch for the NCI Surveillance, Epidemiology and End Results (SEER) Program.  She assisted with the development and publication of technical manuals used by cancer registry professionals and also chaired the Health Disparities Interest Group Seminar Series in the division, providing leadership to address cancer-related disparities. In 2008, she was commissioned into the U.S. Public Health Service Commissioned Corps as a Health Services Officer in the Cancer Statistics Branch at NCI.

Dr. Percy-Laurry received her Doctor of Public Health degree from the School of Community Health and Policy at Morgan State University, a Master of Science in Public Health with a specialization in health behavior from the University of Alabama at Birmingham, and a Bachelor of Science in Biology from Oakwood University. Prior to joining NCI, Dr. Percy-Laurry worked in field studies and clinical trials, including the Women’s Health Initiative Program and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Select Publications